Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)Ended earlyNCT04832139
What this trial is testing

Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Who this might be right for
Healthy Volunteers
Pfizer 22
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Early research (Phase 1)Study completedNCT02083965
What this trial is testing

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

Who this might be right for
Severe Hemophilia A
Bioverativ Therapeutics Inc. 19
Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Not applicableUnknownNCT00797381
What this trial is testing

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Who this might be right for
HIV InfectionHemophilia A
Shanghai Public Health Clinical Center 100
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT04091386
What this trial is testing

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

Who this might be right for
Hemophilia A
Bayer 10
Not applicableStudy completedNCT02078427
What this trial is testing

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

Who this might be right for
Hemophilia A
Baxalta now part of Shire 951
Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Not applicableNot Yet RecruitingNCT07653139
What this trial is testing

Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany

Who this might be right for
Haemophilia A
Novo Nordisk A/S 150
Not applicableApproved For MarketingNCT03154437
What this trial is testing

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

Who this might be right for
Hemophilia A
Genentech, Inc.
Large-scale testing (Phase 3)Study completedNCT02973087
What this trial is testing

RVWF IN PROPHYLAXIS

Who this might be right for
Von Willebrand Disease
Takeda 29
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Not applicableLooking for participantsNCT04119908
What this trial is testing

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Who this might be right for
Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille 400
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Not applicableLooking for participantsNCT03695978
What this trial is testing

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Who this might be right for
Haemophilia A
Octapharma 200
Large-scale testing (Phase 3)Study completedNCT06399289
What this trial is testing

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Who this might be right for
Hemophilia B
CSL Behring 23
Not applicableUnknownNCT04845555
What this trial is testing

Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions

Who this might be right for
Hemophilia A
Prof. Dr. Dr. Thomas Hilberg 30
Next Page